Given the well-established relationship between Aβ and tau deposition in AD (9, 10) such influence of LDL-C on tau protein raises the possibility that LDL-C level may synergistically increase tau deposition with Aβ pathology. The gene discussed is MAPT; the disease is Alzheimer disease.